Seelos Therapeutics, Inc. (SEELQ) — Tangible Net Worth Ratio
Seelos Therapeutics, Inc. (SEELQ) has a Tangible Net Worth Ratio of 100.0% as of December 2021. This metric is calculated by deducting intangible assets ($0.00) from net assets ($57.32 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore SEELQ net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Seelos Therapeutics, Inc. Tangible Net Worth Ratio (2020–2021)
This chart shows how Seelos Therapeutics, Inc.'s Tangible Net Worth Ratio has changed across 2 annual periods from 2020 to 2021. As of December 2021, the ratio stands at 100.0%, reflecting net assets of $57.32 Million with intangible assets of $0.00 USD. For live market cap and overall valuation, see market cap of Seelos Therapeutics, Inc..
Annual Tangible Net Worth Ratio for Seelos Therapeutics, Inc. (2020–2021)
The table below presents the year-by-year Tangible Net Worth Ratio for Seelos Therapeutics, Inc. from 2020 to 2021, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See financial agility of Seelos Therapeutics, Inc. to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2021 | 100.0% | $57.32 Million | $0.00 | $83.50 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $2.57 Million | $0.00 | $17.49 Million | — |